NCT01987219View on ClinicalTrials.gov

The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial Dysautonomia

PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Familial Dysautonomia
Interventions
DRUG

Albuterol-sulphate

Beta-2-adrenergic agonist 2.5 mg 3 cc inhalation Peak effect 15 - 30 mins. Mean duration of effect 3 hours

DRUG

Ipratropium-bromide

Anti-cholinergic 500 mcg 3 cc inhalation Peak effect 30 - 90 mins. Duration of effect 2 - 4 hours.

OTHER

placebo

Saline solution 3 cc NA

Trial Locations (1)

10016

NYU Medical Center, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT01987219 - The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial Dysautonomia | Biotech Hunter | Biotech Hunter